Multicenter study confirms low testosterone in 84 percent of lung cancer patients taking crizotinib

A study published this week in the journal Cancer confirms the finding of low-testosterone in crizotinib patients, and for the first time details the mechanism of reduced testosterone, and provides promising preliminary evidence that widely available hormone replacement therapies can alleviate this side effect in many patients.

Fuente : http://www.eurekalert.org/pub_releases/2013-04/uoc…


Hacer un comentario